Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 Biomarker BEFREE In order to address some of these shortcomings, we have analyzed a broader set of oxidative stress biomarkers in our exploratory study, including urinary 8-iso-prostaglandin F2α (8-iso-PGF2α), 8-OH-2-deoyxguanosine (8-OH-2-dG), and blood levels of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione S-transferase (GST) in acutely ill drug-naïve first episode patients with schizophrenia (n = 22), major depression (n = 18), and controls (n = 43). 27913877

2018

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation BEFREE A previous genome-wide association study (GWAS) of schizophrenia conducted in the Swedish population demonstrated a significant association of rs6878284, which is located in the SLCO6A1 gene, with schizophrenia. 26861727

2016

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation GWASCAT Genome-wide association study of schizophrenia in Ashkenazi Jews. 26198764

2015

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation BEFREE The association between polymorphisms of glutathione-related enzyme (GST) genes and the risk of schizophrenia has been investigated in many published studies. 26295386

2015

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 Biomarker BEFREE Therefore, GST genes may exemplify molecular connectors between ATDILI and SCZ. 26046920

2015

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation BEFREE Thus, here we studied Glutathione S-transferase (GST) A1 polymorphism and diffusion tensor imaging-mean diffusivity (MD) data on deep grey matter brain structures in 56 patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revised (DSM-IV-TR) schizophrenia. 22959778

2013

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation GWASDB Genome-wide association analysis identifies 13 new risk loci for schizophrenia. 23974872

2013

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation GWASCAT Genome-wide association analysis identifies 13 new risk loci for schizophrenia. 23974872

2013

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation BEFREE We found that the combination of the absence of GSTM1 gene with the of the GSTM1 gene with the polymorphism GSTA1*B/*B, and the presence of the GSTT1 gene, represents a risk factor for schizophrenia, indicating that the combination of different GST polymorphisms has a role in the predisposition to schizophrenia, probably affecting the capacity of the cell to detoxify the oxidized metabolites of catecholamines. 21093063

2011

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation BEFREE Furthermore, among the few relatively common CNVs observed in patients and controls, the combined analysis of gene copy number genotypes at two glutathione S-transferase (GST) genes, GSTM1 (glutathione S-transferase mu 1) (1p13.3) and GSTT2 (glutathione S-transferase theta 2) (22q11.23), showed a statistically significant association of non-null genotypes at both loci with an additive effect for increased vulnerability to schizophrenia (odds ratio of 1.92; P=0.0008). 19528963

2010

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.180 GeneticVariation BEFREE These results suggest that GST gene polymorphisms do not confer increased susceptibility to TD in patients with schizophrenia but TD severity might be related with GST-P1 variants. 19051221

2009

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 GeneticVariation BEFREE Exposure to environmental pollutant organochlorine pesticides (OCPs) and the role of tumour suppressor GSTs gene polymorphisms as well as epigenetic alterations have all been well reported in hepatocarcinogenesis. 31731000

2020

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.100 GeneticVariation BEFREE After adjusting for confounders (HBV infection, smoking, alcohol consumption, BMI, age, gender), OCPs exposure and GSTP1 methylation is significantly associated with elevated risk of HCC, while no significance is observed for GSTs polymorphisms. 31731000

2020

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.100 GeneticVariation BEFREE Our findings did not reveal any correlation between the investigated polymorphisms of GST genes and BC risk among Jordanian women. 31571925

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.100 AlteredExpression BEFREE In conclusion, our data may help to guide researchers for further development of sensing systems for GST activity which is impaired in various diseases including cancer. 31452310

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.100 Biomarker BEFREE The degree of intracellular drug accumulation by specific membrane transporters, i.e., MDR1, BCRP, and MRP, and the degree of detoxification by intracellular metabolic enzymes, i.e., CYP3A4 and GST, provide control for cancer chemotherapy through diminishing the propensity of cancer cells to undergo apoptosis which in turn modulates the unresolved and complex phenomenon of multidrug resistance (MDR) for the cancer cells. 30668439

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.100 GeneticVariation BEFREE Polymorphic changes in the GST genes have been reported to be associated with increased susceptibility to cancer development and anticancer drug resistance. 31646988

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.100 Biomarker BEFREE PCAF positively regulated H3S28ph in osteosarcoma cancer cells; Immunoprecipitation assay and GST pull down demonstrated that PCAF could interact directly with H3 in osteosarcoma cancer cells. 31545241

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.100 Biomarker BEFREE Therefore, GSTP<sub>1-1</sub> is an important target in cancer therapy, and many GST inhibitors have been reported. 30548113

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.100 Biomarker BEFREE The aim of the present study was to evaluate the activity of antioxidant enzymes, such as superoxide dismutase (SOD; isoforms: Cu/ZnSOD and MnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione S-transferase (GST), along with the concentration of malondialdehyde (MDA) in tumor and adjacent noncancerous tissues of two histological types of NSCLC, i.e., adenocarcinoma and squamous cell carcinoma, collected from 53 individuals with surgically resectable NSCLC. 31781331

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.100 GeneticVariation BEFREE Aim of this study was to investigate GST gene variants as risk factors in patients with CRC. 30694518

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.100 GeneticVariation BEFREE This study aims to investigate the genetic association of acute myeloid leukemia and glutathione S-transferase (GST) gene polymorphisms in a Saudi population. 31762621

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression BEFREE By reducing intracellular ATP level and GST activity, PTX-DSF Ns killed the Taxol resistant A549 cells with higher efficiency than PTX alone, exhibiting as 6-fold increase of apoptosis in MDR tumor. 30599232

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression BEFREE To test this hypothesis and to gain insights into the mechanisms of precancerous lesion formation, we (i) investigated whether excretory parasitic GST σ retains its enzymatic activity, (ii) tested resveratrol (RSV) as a possible inhibitor of this enzyme, and (iii) assessed biliary neoplasia and oxidative DNA damage as well as the expression of neoplasia and fibrogenesis marker genes after prolonged administration of RSV in a hamster model. 31628937

2019

Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker BEFREE The aim of the present study was to evaluate the activity of antioxidant enzymes, such as superoxide dismutase (SOD; isoforms: Cu/ZnSOD and MnSOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione S-transferase (GST), along with the concentration of malondialdehyde (MDA) in tumor and adjacent noncancerous tissues of two histological types of NSCLC, i.e., adenocarcinoma and squamous cell carcinoma, collected from 53 individuals with surgically resectable NSCLC. 31781331

2019